Potent Fc Receptor Signaling by IgA Leads to Superior Killing of Cancer Cells by Neutrophils Compared to IgG

Antibody therapy of cancer is increasingly used in the clinic and has improved patient's life expectancy. Except for immune checkpoint inhibition, the mode of action of many antibodies is to recognize overexpressed or specific tumor antigens and initiate either direct F(ab′)(2)-mediated tumor c...

Descripción completa

Detalles Bibliográficos
Autores principales: Brandsma, Arianne M., Bondza, Sina, Evers, Mitchell, Koutstaal, Rosanne, Nederend, Maaike, Jansen, J. H. Marco, Rösner, Thies, Valerius, Thomas, Leusen, Jeanette H. W., ten Broeke, Toine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6470253/
https://www.ncbi.nlm.nih.gov/pubmed/31031746
http://dx.doi.org/10.3389/fimmu.2019.00704

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6470253/
https://www.ncbi.nlm.nih.gov/pubmed/31031746
http://dx.doi.org/10.3389/fimmu.2019.00704

Ejemplares similares